MeSH term
Frequency | Condition_Probility | Humans | 74 | 0.0 |
Animals | 46 | 0.0 |
Base Sequence | 10 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cell Line | 18 | 0.0 |
Gene Expression Regulation | 3 | 0.0 |
Mice | 34 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 58 | 0.0 |
Antigens, CD/*immunology | 9 | 1.0 |
Antigens, Differentiation, B-Lymphocyte/*immunology | 8 | 11.0 |
B-Lymphocytes/*immunology | 15 | 1.0 |
Ligands | 11 | 0.0 |
Membrane Glycoproteins/immunology | 2 | 1.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
*Semaphorins | 8 | 33.0 |
Signal Transduction/immunology | 2 | 0.0 |
Antigens, CD/*biosynthesis/genetics | 3 | 5.0 |
Antigens, Differentiation, B-Lymphocyte/*biosynthesis/genetics | 3 | 50.0 |
B-Lymphocytes/drug effects/*immunology | 2 | 6.0 |
Gene Expression | 2 | 0.0 |
Lymphocyte Activation | 13 | 0.0 |
Mice, Inbred C57BL | 5 | 0.0 |
Mice, Knockout | 2 | 0.0 |
English Abstract | 6 | 0.0 |
Immunity, Cellular | 3 | 0.0 |
Immunophenotyping | 4 | 0.0 |
Tumor Necrosis Factor-alpha/metabolism | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Female | 17 | 0.0 |
Molecular Sequence Data | 12 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 4 | 0.0 |
Adult | 14 | 0.0 |
Aged | 7 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
B-Lymphocytes/*cytology | 3 | 4.0 |
Comparative Study | 10 | 0.0 |
Flow Cytometry | 11 | 0.0 |
Male | 11 | 0.0 |
Middle Aged | 13 | 0.0 |
Neoplasm Proteins/physiology | 2 | 3.0 |
Neoplasm Staging | 2 | 0.0 |
Adolescent | 2 | 0.0 |
Blotting, Western | 3 | 0.0 |
Signal Transduction | 8 | 0.0 |
B-Lymphocytes/cytology/*immunology | 2 | 2.0 |
Cell Adhesion Molecules/*immunology | 2 | 3.0 |
Lectins/*immunology | 3 | 11.0 |
Lymphocyte Activation/immunology | 4 | 0.0 |
Signal Transduction/*immunology | 4 | 1.0 |
Antigens, CD/metabolism/*physiology | 2 | 7.0 |
Immune System/*physiology | 2 | 3.0 |
Lymphocytes/metabolism | 2 | 0.0 |
B-Lymphocytes/metabolism | 2 | 1.0 |
Cloning, Molecular | 6 | 0.0 |
Alleles | 2 | 0.0 |
Antigens, CD/*genetics | 2 | 0.0 |
Antigens, Differentiation, B-Lymphocyte/*genetics | 2 | 9.0 |
*B-Lymphocytes | 2 | 6.0 |
Spleen/cytology | 2 | 1.0 |
Antigens, CD/chemistry/genetics | 2 | 50.0 |
Cell Line, Transformed | 2 | 0.0 |
Chickens | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Protein Kinase C/physiology | 2 | 1.0 |
Signal Transduction/genetics/*immunology | 2 | 2.0 |
*Antigens, CD | 4 | 0.0 |
Mice, Inbred BALB C | 8 | 0.0 |
Solubility | 2 | 0.0 |
T-Lymphocytes/*immunology | 8 | 0.0 |
B-Lymphocytes/*metabolism | 4 | 2.0 |
Down-Regulation | 2 | 0.0 |
Phosphorylation | 8 | 0.0 |
Protein-Tyrosine-Phosphatase/*metabolism | 2 | 1.0 |
Receptors, Antigen, B-Cell/*metabolism | 4 | 5.0 |
Substrate Specificity | 3 | 0.0 |
Tumor Cells, Cultured | 9 | 0.0 |
CHO Cells | 3 | 0.0 |
Hamsters | 3 | 0.0 |
Membrane Glycoproteins/*immunology | 2 | 1.0 |
Receptors, Immunologic/*immunology | 2 | 1.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Antibodies, Monoclonal | 6 | 0.0 |
Antibody Formation | 2 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Antigens, CD/immunology | 3 | 0.0 |
Antigens, Differentiation, B-Lymphocyte/immunology | 3 | 5.0 |
Biological Markers | 2 | 0.0 |
T-Lymphocytes/*immunology/metabolism | 3 | 1.0 |
Calcium/metabolism | 2 | 0.0 |
Mice, Inbred DBA | 5 | 1.0 |
Transfection | 9 | 0.0 |
Antibody Formation/physiology | 2 | 14.0 |
Antigens, CD5/metabolism | 2 | 10.0 |
*Cell Communication | 2 | 2.0 |
Cytokines/metabolism | 2 | 0.0 |
Membrane Glycoproteins/metabolism | 2 | 0.0 |
Antigens, CD5/*metabolism | 2 | 9.0 |
Binding Sites | 2 | 0.0 |
Cell Membrane/immunology | 2 | 0.0 |
In Vitro | 3 | 0.0 |
Precipitin Tests | 3 | 0.0 |
Recombinant Fusion Proteins/metabolism | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Cytokines/immunology | 2 | 1.0 |
Antigen Presentation | 2 | 0.0 |
Cells, Cultured | 9 | 0.0 |
Antigens, CD/*metabolism | 9 | 1.0 |
Antigens, Differentiation, B-Lymphocyte/*metabolism | 6 | 16.0 |
B-Lymphocytes/cytology/*metabolism | 3 | 12.0 |
Enzyme Activation | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
*Lymphocyte Activation | 6 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 2 | 0.0 |
Receptors, Complement 3d/metabolism | 2 | 28.0 |
Tyrosine/metabolism | 3 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Nuclear Proteins/genetics/metabolism | 2 | 1.0 |
T-Lymphocytes/metabolism | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Cell Division | 3 | 0.0 |
Phosphotyrosine | 3 | 1.0 |
Spleen/immunology | 2 | 1.0 |
Mice, Inbred Strains | 2 | 0.0 |
Antigens, CD/genetics | 2 | 1.0 |
Histocompatibility Antigens Class II/*physiology | 2 | 9.0 |
Antigens, CD/*physiology | 6 | 1.0 |
Antigens, Differentiation, B-Lymphocyte/*physiology | 5 | 14.0 |
Antigens, CD5/*analysis | 2 | 5.0 |
*Antibodies, Monoclonal | 2 | 0.0 |
Child | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
B-Lymphocyte Subsets/*metabolism | 2 | 25.0 |
Immunoglobulins, Surface/metabolism | 2 | 10.0 |
Antigens, Differentiation, B-Lymphocyte/metabolism | 4 | 6.0 |
Phenotype | 6 | 0.0 |
Antibodies, Monoclonal/immunology | 5 | 0.0 |
Interleukin-2/immunology | 2 | 1.0 |
Lymphocyte Cooperation | 3 | 3.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
T-Lymphocyte Subsets/*immunology | 3 | 0.0 |
Cytokines/physiology | 2 | 1.0 |
Antigens, CD/metabolism | 4 | 0.0 |
Antigens, CD40/immunology | 2 | 3.0 |
Interleukin-4/pharmacology | 2 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Recombinant Proteins/immunology | 2 | 0.0 |
*Signal Transduction | 3 | 0.0 |
Antigens, CD/analysis | 5 | 0.0 |
Dendritic Cells/immunology | 3 | 2.0 |
Time Factors | 2 | 0.0 |
Immunoenzyme Techniques | 3 | 0.0 |
*N-Glycosyl Hydrolases | 2 | 3.0 |
Antigens, CD40 | 3 | 5.0 |
Up-Regulation/immunology | 2 | 1.0 |
Sjogren's Syndrome/*immunology | 2 | 6.0 |
Antigens, CD5 | 9 | 3.0 |
Rats | 3 | 0.0 |
Leukemia, B-Cell, Chronic/*immunology | 2 | 4.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
*Nerve Tissue Proteins | 3 | 0.0 |
*Receptors, Cell Surface | 3 | 0.0 |
Antigens, Surface/analysis | 2 | 0.0 |
Molecular Weight | 2 | 0.0 |
B-Lymphocyte Subsets/*immunology | 2 | 2.0 |
Clone Cells | 3 | 0.0 |
Immunoglobulin M/biosynthesis | 2 | 2.0 |
Antigens, CD19 | 6 | 3.0 |
Cross-Linking Reagents | 2 | 0.0 |
Interleukin-2/pharmacology | 2 | 0.0 |
Cell Adhesion Molecules/physiology | 2 | 2.0 |
*Cytotoxicity, Immunologic | 3 | 0.0 |
Intercellular Adhesion Molecule-1 | 2 | 0.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Interleukin-4/*pharmacology | 2 | 0.0 |
Antigens, CD28 | 2 | 1.0 |
Antigens, Differentiation, B-Lymphocyte/*biosynthesis/*physiology | 2 | 100.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Receptors, Fc/*biosynthesis | 2 | 22.0 |
Receptors, IgE | 4 | 6.0 |
B-Lymphocytes/immunology | 5 | 0.0 |
Antigens, CD/analysis/genetics/*physiology | 2 | 25.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Receptors, Antigen, T-Cell/*immunology | 2 | 1.0 |
Protein Binding | 3 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Models, Immunological | 2 | 0.0 |
Semaphorins/*immunology | 2 | 100.0 |
